After falling 17 per cent since the start of the year to its March lows, the stock of the country's largest pharmaceutical ...

Sun Pharma successfully removed an injunction in the US on the launch of its Leqselvi for alopecia areata, a common form of hair loss, that was sought by rival Incyte. The decision in the US Court ...

A US district court has granted an injunction sought by Incyte on the launch of Sun Pharma's recently approved Leqselvi for alopecia areata. In a brief filing with the National Stock Exchange (NSE ...

According to market estimates, Leqselvi is projected to contribute $90 million to Sun Pharma's sales in FY26, and $125 million in FY27 ...

One of the popular hypertension medication brands Telma 40 samples were found to be spurious in raids across locations ...

USFDA, via email communication dated 11th April, 2025 (received by Medispray), has classified the inspection at the ...

ABB announced today that it will launch a process to propose to its Annual General Meeting 2026 to decide on a 100 percent ...

Sun Pharmaceutical Industries, operating in the Pharmaceuticals sector and classified as a Largecap on the BSE, currently has its share price at ₹1751.95. The stock has experienced fluctuations ...

Sun Pharmaceutical Industries Ltd. is a Public Limited Listed company incorporated on 01/03/1993 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number ...